01 1Dasami Lab
01 1CANAGLIFLOZIN HEMIHYDRATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-04-17
Pay. Date : 2017-01-17
DMF Number : 31231
Submission : 2017-03-16
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CANAGLIFLOZIN HEMIHYDRATE, with a corresponding US DMF Number 31231.
Remarkably, this DMF maintains an Active status since its submission on March 16, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 17, 2017, and payment made on January 17, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
